Evaluation of safety, pharmacokinetics, and pharmacodynamics of apixaban in pediatric subjects at risk of venous or arterial thrombotic disorder von Merali, Samira J., Byon, Wonkyung, Patel, Yogesh T., Elsrougy, Amira, Marchisin, David, Perera, Vidya, Chen, Weidong, He, Bing, Murthy, Bindu

Volltext

Clinical Implications of Co‐administering Apixaban with Key Interacting Medications von Favatella, Nicholas, Dalton, David, Byon, Wonkyung, Merali, Samira J., Klem, Christian

Volltext

Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data von Jamieson, Michael J., Byon, Wonkyung, Dettloff, Richard W., Crawford, Matthew, Gargalovic, Peter S., Merali, Samira J., Onorato, Joelle, Quintero, Andres J., Russ, Cristina

Volltext

USE OF MILVEXIAN FOR TREATING OR PREVENTING ISCHEMIC STROKE von PLOTNIKOV, Alexei, MERALI, Samira J, YAVIN, Yshai, PERERA, Vidya Liyanage, NESSEL, Christopher, KAHL, Anja, LI, Danshi, JONES-BURTON, Charlotte, MOHAN, Puneet

Volltext bestellen

USO DE MILVEXIAN PARA EL TRATAMIENTO O LA PREVENCIÓN DEL ACCIDENTE CEREBROVASCULAR ISQUÉMICO von KAHL, ANJA, MOHAN, PUNEET, NESSEL, CHRISTOPHER, LI, DANSHI, MERALI, SAMIRA J, PERERA, VIDYA LIYANAGE, JONES-BURTON, CHARLOTTE, PLOTNIKOV, ALEXEI, YAVIN, YSHAI

Volltext bestellen

Use of MILVEXIAN for treating or preventing ischemic stroke von KAHL, ANJA, MOHAN, PUNEET, NESSEL, CHRISTOPHER, LI, DANSHI, MERALI, SAMIRA J, PERERA, VIDYA LIYANAGE, JONES-BURTON, CHARLOTTE, PLOTNIKOV, ALEXEI, YAVIN, YSHAI

Volltext bestellen

Abstract 12412: In Silico Evaluation of Dosing Regimens to Accommodate Coadministration of Mavacamten With Strong Inhibitors of Cytochrome P450 3A4 and Moderate Inhibitors of Cytoc... von Merali, Samira, Bunn, Haden, Sychterz, Caroline, Chiang, Manting, puli, Shilpa, Sehnert, Amy J, Murthy, Bindu, Gobburu, Joga

Volltext

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response von Owens, Anjali T, Desai, Milind, Wheeler, Matthew T, Rodonski, Anna, Merali, Samira, Sehnert, Amy J, Saberi, Sara

Volltext

Absolute oral bioavailability of milvexian spray‐dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach von Jarugula, Praneeth, Soleman, Sharif, Back, Hyunmoon, Christopher, Lisa J., Hawthorne, Dara, Aronson, Ronald, Bui, Anh, Mirzac, Angela, Ajavon‐Hartmann, Antoinette, Perera, Vidya, Murthy, Bindu, Merali, Samira

Volltext

Recommendation of mavacamten posology by model‐based analyses in adults with obstructive hypertrophic cardiomyopathy von Merali, Samira, Salinger, David H., Palmisano, Maria, Sehnert, Amy J., Thanneer, Neelima, Back, Hyunmoon, Seroogy, Julie D., Gretler, Daniel D., Roy, Amit, Perera, Vidya

Volltext

Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration von Chang, Peter, Perera, Vidya, Salinger, David H., Merali, Samira, Thanneer, Neelima, Back, Hyunmoon, Seroogy, Julie D., Gretler, Daniel D., Sehnert, Amy J., Palmisano, Maria, Roy, Amit

Volltext

Performance Verification of CYP2C19 Enzyme Abundance Polymorphism Settings within the Simcyp Simulator v21 von Sychterz, Caroline, Gardner, Iain, Chiang, Manting, Rachumallu, Ramakrishna, Neuhoff, Sibylle, Perera, Vidya, Merali, Samira, Schmidt, Brian J, Gaohua, Lu

Volltext